Yuto Baba

Shinjuku, 1608582, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Correction: Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder.

Correction: Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder.

Journal: Scientific reports

Published: September 12, 2025

Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation.

Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation.

Journal: IJU case reports

Published: August 02, 2025

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

MUC1-C dependence in treatment-resistant prostate cancer uncovers a target for antibody-drug conjugate therapy.

Journal: JCI insight

Published: January 14, 2025

A case of testicular dysgenesis syndrome with squamous cell carcinoma of the prostate harboring a CDK12 mutation.

A case of testicular dysgenesis syndrome with squamous cell carcinoma of the prostate harboring a CDK12 mutation.

Journal: IJU case reports

Published: November 23, 2024

Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder.

Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder.

Journal: Scientific reports

Published: November 15, 2024

G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer.

G-protein signaling of oxytocin receptor as a potential target for cabazitaxel-resistant prostate cancer.

Journal: PNAS nexus

Published: July 10, 2023

Prognostic significance of serum testosterone level in patients with castration-resistant prostate cancer treated with cabazitaxel.

Prognostic significance of serum testosterone level in patients with castration-resistant prostate cancer treated with cabazitaxel.

Journal: The Prostate

Published: June 08, 2023

Prognostic role of the innate immune signature CD163 and "eat me" signal calreticulin in clear cell renal cell carcinoma.

Prognostic role of the innate immune signature CD163 and "eat me" signal calreticulin in clear cell renal cell carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: September 26, 2022

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.

Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.

Journal: International journal of clinical oncology

Published: April 13, 2022

IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

IDH2 stabilizes HIF-1α-induced metabolic reprogramming and promotes chemoresistance in urothelial cancer.

Journal: The EMBO journal

Published: January 08, 2022

Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy.

Isolated recurrence of prostate cancer to the anterior urethra 5 years after radiation therapy.

Journal: IJU case reports

Published: September 17, 2021

Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history.

Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history.

Journal: Scientific reports

Published: August 17, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026